Cite
HARVARD Citation
Sulkowski, M. et al. (n.d.). 1223Ledipasvir/Sofosbuvir is Safe and Effective as a Single-Tablet-Regimen for Treatment of Patients with Genotype 1 Chronic Hepatitis C Virus, Including those with Compensated Cirrhosis. Open forum infectious diseases. p. S42. [Online].